Johnson & Johnson (JNJ)

Medical science's capabilities are catching up with what it knows about the genomics of disease. J&J just made sure it's better equipped to utilize the industry's newest capabilities.

New cancer therapies may help fund dividend growth.

It's important to consider your comfort with risk before diving in.

Johnson & Johnson reports Phase 2/3 data showing IMAAVY improved hemoglobin levels in wAIHA patients and secured FDA Priority Review.

These stocks may deliver gains during any market environment.

The Vanguard Dividend Appreciation ETF is the perfect fit for investors looking to build a portfolio around high-quality companies that pay growing dividends.

These AI stocks could massively grow their dividends over the next few years when cash flows are freed up.

Johnson & Johnson takes a licking, and the dividend keeps on ticking higher.

Laser Photonics Corp (NASDAQ:LASE) stock dips on Thursday. Read why traders are taking profits ahead of Q1 earnings despite major Department of War and Johnson & Johnson deals.

This particular sector may suit cautious and aggressive investors.

Wall Street analysts expect market-beating returns from healthcare and communication services stocks over the next year.

AbbVie's shareholders can sleep easy.

The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. exposure, while the other adds global reach in a sector shaped by drug pricing, patent cycles, regulation, and medical innovation.